Hospital-Acquired and Ventilator-Associated Pneumonia

Catia Cillóniz; Cristina Dominedo; Adrian Ceccato; Antoni Torres

doi:10.1016/B978-0-08-102723-3.00176-1

Hospital-Acquired and Ventilator-Associated Pneumonia

Catia Cillóniz
, Cristina Dominedo
, Adrian Ceccato
, Antoni Torres

Research output: Chapter in Book/Report › Chapter › peer-review

Abstract

Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are, together, a major cause of morbidity and mortality despite improvements in their management. Their incidences remain high worldwide and, alongside the increased spread of multidrug-resistant organisms, have become a challenge for physicians and a global public health problem. New results published in the last decade as well as the emergence of new technologies have changed our understanding of the pathophysiology of pneumonia, providing knowledge that can be used to develop new treatments and prevent HAP/VAP.

Original language	American English
Title of host publication	Encyclopedia of Respiratory Medicine, Second Edition
Publisher	Elsevier
Pages	206-219
Number of pages	14
Volume	4
ISBN (Electronic)	9780081027240
ISBN (Print)	9780081027233
DOIs	https://doi.org/10.1016/B978-0-08-102723-3.00176-1
State	Indexed - 1 Jan 2021
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2022 Elsevier Ltd. All rights reserved

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Antimicrobial resistance
Hospital-acquired pneumonia
Infection
Nosocomial pneumonia
Pneumonia
Respiratory infection
Ventilator-associated pneumonia

Access to Document

10.1016/B978-0-08-102723-3.00176-1

Cite this

@inbook{7122afeff8d34debb7d4fb021f0728f8,

title = "Hospital-Acquired and Ventilator-Associated Pneumonia",

abstract = "Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are, together, a major cause of morbidity and mortality despite improvements in their management. Their incidences remain high worldwide and, alongside the increased spread of multidrug-resistant organisms, have become a challenge for physicians and a global public health problem. New results published in the last decade as well as the emergence of new technologies have changed our understanding of the pathophysiology of pneumonia, providing knowledge that can be used to develop new treatments and prevent HAP/VAP.",

keywords = "Antimicrobial resistance, Hospital-acquired pneumonia, Infection, Nosocomial pneumonia, Pneumonia, Respiratory infection, Ventilator-associated pneumonia",

author = "Catia Cill{\'o}niz and Cristina Dominedo and Adrian Ceccato and Antoni Torres",

year = "2021",

month = jan,

day = "1",

doi = "10.1016/B978-0-08-102723-3.00176-1",

language = "American English",

isbn = "9780081027233",

volume = "4",

pages = "206--219",

booktitle = "Encyclopedia of Respiratory Medicine, Second Edition",

publisher = "Elsevier",

address = "Netherlands",

}

TY - CHAP

T1 - Hospital-Acquired and Ventilator-Associated Pneumonia

AU - Cillóniz, Catia

AU - Dominedo, Cristina

AU - Ceccato, Adrian

AU - Torres, Antoni

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are, together, a major cause of morbidity and mortality despite improvements in their management. Their incidences remain high worldwide and, alongside the increased spread of multidrug-resistant organisms, have become a challenge for physicians and a global public health problem. New results published in the last decade as well as the emergence of new technologies have changed our understanding of the pathophysiology of pneumonia, providing knowledge that can be used to develop new treatments and prevent HAP/VAP.

AB - Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are, together, a major cause of morbidity and mortality despite improvements in their management. Their incidences remain high worldwide and, alongside the increased spread of multidrug-resistant organisms, have become a challenge for physicians and a global public health problem. New results published in the last decade as well as the emergence of new technologies have changed our understanding of the pathophysiology of pneumonia, providing knowledge that can be used to develop new treatments and prevent HAP/VAP.

KW - Antimicrobial resistance

KW - Hospital-acquired pneumonia

KW - Infection

KW - Nosocomial pneumonia

KW - Pneumonia

KW - Respiratory infection

KW - Ventilator-associated pneumonia

UR - https://www.scopus.com/pages/publications/85143089824

U2 - 10.1016/B978-0-08-102723-3.00176-1

DO - 10.1016/B978-0-08-102723-3.00176-1

M3 - Chapter

AN - SCOPUS:85143089824

SN - 9780081027233

VL - 4

SP - 206

EP - 219

BT - Encyclopedia of Respiratory Medicine, Second Edition

PB - Elsevier

ER -

Hospital-Acquired and Ventilator-Associated Pneumonia

Abstract

Bibliographical note

UN SDGs

Keywords

Access to Document

Fingerprint

Cite this